Tin T Hla, MD
Medical Oncology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hla’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A36657 · Current
Licensed to practise in California · since 1981 · expires 2028-06-30 · Institute of Medicine (I) Rangoon.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$32,103
Medicare paid this office $32,103 for 91 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 85 | $20,403 | $115 |
| Short return visit (20+ min) | 34 | $9,697 | $87 |
Who their Medicare patients are
91 Original Medicare patients in 2024. Average age 77 · Women 66% · Also on Medicaid 52% · Health risk score 1.27. At or below the middle of the specialty; the typical medical oncology clinician is at 2.11.
Conditions among them: High blood pressure 70% · Diabetes 38% · Cancer 38% · Chronic kidney disease 30% · Coronary heart disease 26% · Atrial fibrillation 15% · COPD 12%.
The office billed $57,105, Medicare allowed $42,363 and paid $32,103; for 304 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 91 | 304 | 77 | 1.27 | $57,105 | $32,103 |
| 2023 | 91 | 269 | 77 | 1.36 | $48,445 | $24,369 |
| 2022 | 104 | 318 | 77 | 1.19 | $58,740 | $29,365 |
| 2021 | 95 | 315 | 77 | 1.39 | $60,770 | $30,971 |
| 2020 | 101 | 432 | 77 | 1.46 | $83,420 | $35,125 |
| 2019 | 143 | 697 | 76 | 1.68 | $130,225 | $55,771 |
| 2018 | 139 | 758 | 76 | 1.65 | $144,690 | $67,111 |
| 2017 | 156 | 805 | 77 | 1.73 | $157,331 | $66,588 |
| 2016 | 143 | 469 | 77 | 1.90 | $92,015 | $42,305 |
| 2015 | 178 | 707 | 76 | 1.78 | $154,890 | $60,762 |
| 2014 | 279 | 1,092 | 76 | 1.72 | $238,785 | $95,293 |
| 2013 | 315 | 1,259 | 76 | 1.67 | $268,530 | $116,287 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 72 | $12,973 | $113 |
| Short return visit (20+ min) | 56 | $10,225 | $72 |
2022: 3 services
| Short return visit (20+ min) | 79 | $15,902 | $78 |
| Return visit (30+ min) | 56 | $8,670 | $116 |
| New patient visit (45+ min) | 20 | $2,836 | $142 |
2021: 3 services
| Return visit (30+ min) | 78 | $13,888 | $104 |
| Short return visit (20+ min) | 56 | $11,159 | $83 |
| New patient visit (45+ min) | 17 | $2,539 | $149 |
2020: 2 services
| Return visit (30+ min) | 84 | $14,151 | $86 |
| Short return visit (20+ min) | 65 | $10,435 | $61 |
2019: 5 services
| Short return visit (20+ min) | 106 | $27,533 | $66 |
| Return visit (30+ min) | 97 | $13,903 | $90 |
| New patient visit (45+ min) | 26 | $3,834 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,588 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $215 | $17 |
2018: 6 services
| Short return visit (20+ min) | 93 | $27,203 | $71 |
| Return visit (30+ min) | 100 | $17,382 | $92 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 13 | $8,471 | $157 |
| New patient visit (45+ min) | 28 | $4,495 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $2,282 | $134 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $453 | $16 |
2017: 8 services
| Short return visit (20+ min) | 92 | $22,369 | $63 |
| Return visit (30+ min) | 121 | $22,057 | $88 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 11 | $10,088 | $146 |
| New patient visit (45+ min) | 27 | $3,405 | $126 |
| New patient visit (60+ min) | 11 | $1,886 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,539 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,360 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $223 | $14 |
2016: 5 services
| Return visit (30+ min) | 101 | $17,778 | $98 |
| Short return visit (20+ min) | 54 | $11,262 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,857 | $179 |
| New patient visit (45+ min) | 14 | $2,064 | $147 |
| New patient visit (60+ min) | 12 | $1,973 | $164 |
2015: 8 services
| Return visit (30+ min) | 80 | $16,578 | $93 |
| Short return visit (20+ min) | 57 | $12,715 | $64 |
| Complete ultrasound scan of abdomen | 59 | $7,178 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,765 | $176 |
| New patient visit (60+ min) | 24 | $4,449 | $185 |
| Complete ultrasound scan behind abdominal cavity | 59 | $3,831 | $64 |
| Ultrasound scan of head and neck soft tissue | 15 | $1,861 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,815 | $91 |
2014: 11 services
| Short return visit (20+ min) | 103 | $23,646 | $68 |
| Complete ultrasound scan of abdomen | 126 | $17,760 | $138 |
| Return visit (30+ min) | 102 | $17,237 | $97 |
| New patient visit (60+ min) | 28 | $5,275 | $188 |
| Ultrasound scan of head and neck soft tissue | 36 | $4,870 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,957 | $180 |
| Complete ultrasound scan behind abdominal cavity | 47 | $3,499 | $74 |
| Limited ultrasound scan behind abdominal cavity | 81 | $3,178 | $39 |
| New patient visit (45+ min) | 17 | $2,458 | $145 |
| Administration of influenza virus vaccine | 12 | $373 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 12 | $181 | $15 |
2013: 9 services
| Return visit (30+ min) | 133 | $28,816 | $98 |
| Complete ultrasound scan of abdomen | 166 | $23,117 | $136 |
| Short return visit (20+ min) | 94 | $22,642 | $68 |
| Limited ultrasound scan behind abdominal cavity | 163 | $10,403 | $62 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 18 | $10,046 | $146 |
| Ultrasound scan of head and neck soft tissue | 36 | $5,843 | $127 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,560 | $175 |
| New patient visit (60+ min) | 21 | $3,934 | $187 |
| Long return visit (40+ min) | 11 | $1,343 | $122 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 14 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 14 | $0 |
| 2024 | 14 | 1 | 14 | $0 |
| 2023 | 54 | 2 | 28 | $120 |
| 2022 | 59 | 1 | 15 | $0 |
| 2021 | 59 | 2 | 13 | $145 |
| 2020 | 14 | 1 | 13 | $0 |
| 2019 | 72 | 2 | 15 | $56 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 28 | $120 |
| Return visit (30+ min) | 26 | $0 |
2022
| Short return visit (20+ min) | 59 | $0 |
2021
| Return visit (30+ min) | 12 | $145 |
| Short return visit (20+ min) | 47 | $0 |
2020
| Return visit (30+ min) | 14 | $0 |
2019
| Return visit (30+ min) | 15 | $32 |
| Short return visit (20+ min) | 57 | $24 |
Drugs they prescribed that Part D paid
$1,121,703
Pharmacies billed $1,121,703 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,391 generic and fewer than 11 brand-name prescriptions · $1,121,703 in drug cost · 25 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tagrisso | 22 | $325,126 | $14,778 |
| Calquence | 13 | $199,905 | $15,377 |
| Januvia | 15 | $11,510 | $767 |
| Tradjenta | 16 | $7,430 | $464 |
| Eliquis | 13 | $7,407 | $570 |
See all 35 drugs
| Tagrisso | 22 | $325,126 | $14,778 |
| Calquence | 13 | $199,905 | $15,377 |
| Januvia | 15 | $11,510 | $767 |
| Tradjenta | 16 | $7,430 | $464 |
| Eliquis | 13 | $7,407 | $570 |
| Exemestane | 12 | $4,079 | $340 |
| Raloxifene | 72 | $2,370 | $33 |
| Letrozole | 79 | $2,003 | $25 |
| Erlotinib | 13 | $1,893 | $146 |
| Levothyroxine | 61 | $1,676 | $27 |
| Atorvastatin | 137 | $1,665 | $12 |
| Anastrozole | 47 | $1,524 | $32 |
| Alendronate | 97 | $1,137 | $12 |
| Losartan | 84 | $852 | $10 |
| Diclofenac | 34 | $831 | $24 |
| Simvastatin | 93 | $655 | $7 |
| Amlodipine Besylate | 86 | $646 | $8 |
| Megestrol Acetate | 16 | $618 | $39 |
| Rosuvastatin | 26 | $488 | $19 |
| Metformin | 38 | $394 | $10 |
| Metoprolol | 32 | $382 | $12 |
| Ibandronate | 13 | $345 | $27 |
| Omeprazole | 31 | $317 | $10 |
| Potassium Chloride | 16 | $311 | $19 |
| Gabapentin | 29 | $224 | $8 |
| Metformin Hcl Er | 20 | $207 | $10 |
| Losartan-Hydrochlorothiazide | 13 | $203 | $16 |
| Famotidine | 29 | $181 | $6 |
| Hydroxyurea | 13 | $168 | $13 |
| Lisinopril | 19 | $141 | $7 |
| Clopidogrel | 13 | $131 | $10 |
| Tamsulosin | 12 | $129 | $11 |
| Triamcinolone Acetonide | 17 | $74 | $4 |
| Zolpidem | 26 | $42 | $2 |
| Amoxicillin | 14 | $30 | $2 |
Year by year
| 2024 | 1,580 | 193 | None | None | $1,121,703 |
| 2023 | 1,575 | 169 | None | 11% | $711,839 |
| 2022 | 1,511 | 182 | None | 14% | $661,904 |
| 2021 | 1,394 | 162 | None | 13% | $603,576 |
| 2020 | 1,895 | 197 | None | None | $862,019 |
| 2019 | 2,068 | 223 | 1% (22) | None | $1,117,135 |
| 2018 | 2,104 | 207 | None | 19% | $1,279,367 |
| 2017 | 1,678 | 194 | 1% (17) | None | $1,015,164 |
| 2016 | 1,191 | 156 | None | None | $931,384 |
| 2015 | 1,123 | 160 | 2% (17) | None | $643,367 |
| 2014 | 832 | 146 | None | None | $684,542 |
| 2013 | 569 | 129 | 2% (12) | 41% | $618,892 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Calquence | 12 | $192,296 | $16,025 |
| Tagrisso | 13 | $96,259 | $7,405 |
| Eliquis | 13 | $12,724 | $979 |
| Januvia | 17 | $10,974 | $646 |
| Raloxifene | 62 | $8,646 | $139 |
| Letrozole | 74 | $7,891 | $107 |
| Erlotinib | 13 | $7,558 | $581 |
| Atorvastatin | 160 | $3,285 | $21 |
| Levothyroxine | 68 | $2,587 | $38 |
| Losartan | 108 | $2,041 | $19 |
| Megestrol Acetate | 15 | $1,617 | $108 |
| Simvastatin | 89 | $1,392 | $16 |
| Alendronate | 71 | $1,335 | $19 |
| Anastrozole | 26 | $1,225 | $47 |
| Diclofenac | 24 | $1,188 | $50 |
| Metformin | 48 | $1,096 | $23 |
| Amlodipine Besylate | 76 | $1,016 | $13 |
| Hydroxyurea | 21 | $916 | $44 |
| Rosuvastatin | 24 | $911 | $38 |
| Tamsulosin | 13 | $727 | $56 |
| Metoprolol | 25 | $547 | $22 |
| Gabapentin | 35 | $436 | $12 |
| Lisinopril | 34 | $433 | $13 |
| Pioglitazone | 15 | $393 | $26 |
| Famotidine | 25 | $388 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $323 | $29 |
| Clopidogrel | 12 | $307 | $26 |
| Azelastine | 11 | $301 | $27 |
| Omeprazole | 22 | $287 | $13 |
| Metformin Hcl Er | 22 | $261 | $12 |
| Hydrochlorothiazide | 11 | $195 | $18 |
| Metoprolol | 11 | $176 | $16 |
| Zolpidem | 25 | $131 | $5 |
| Triamcinolone Acetonide | 12 | $107 | $9 |
| Easy Touch Alcohol Prep Pads | 11 | $85 | $8 |
| Amoxicillin | 12 | $51 | $4 |
2022: 35 drugs
| Nerlynx | 11 | $73,912 | $6,719 |
| Tagrisso | 13 | $60,885 | $4,683 |
| Eliquis | 12 | $15,095 | $1,258 |
| Procrit | 11 | $12,702 | $1,155 |
| Raloxifene | 55 | $10,023 | $182 |
| Exemestane | 11 | $6,541 | $595 |
| Lantus Solostar | 13 | $5,193 | $399 |
| Letrozole | 93 | $3,181 | $34 |
| Icosapent Ethyl | 11 | $3,094 | $281 |
| Erlotinib | 12 | $2,262 | $189 |
| Tamsulosin | 18 | $2,250 | $125 |
| Levothyroxine | 61 | $1,665 | $27 |
| Atorvastatin | 110 | $1,561 | $14 |
| Alendronate | 91 | $1,396 | $15 |
| Losartan | 95 | $1,324 | $14 |
| Megestrol Acetate | 16 | $1,190 | $74 |
| Simvastatin | 104 | $1,174 | $11 |
| Anastrozole | 24 | $1,063 | $44 |
| Rivastigmine | 11 | $869 | $79 |
| Amlodipine Besylate | 69 | $789 | $11 |
| Rosuvastatin | 19 | $559 | $29 |
| Gabapentin | 39 | $522 | $13 |
| Metformin | 45 | $519 | $12 |
| Potassium Chloride | 11 | $498 | $45 |
| Hydroxyurea | 16 | $453 | $28 |
| Lisinopril | 24 | $287 | $12 |
| Clopidogrel | 19 | $271 | $14 |
| Metoprolol | 14 | $249 | $18 |
| Metformin Hcl Er | 15 | $245 | $16 |
| Triamcinolone Acetonide | 26 | $241 | $9 |
| Dexamethasone | 12 | $233 | $19 |
| Omeprazole | 24 | $204 | $9 |
| Metoprolol | 16 | $195 | $12 |
| Hydrochlorothiazide | 15 | $173 | $12 |
| Pantoprazole | 11 | $170 | $15 |
2021: 35 drugs
| Tagrisso | 20 | $183,357 | $9,168 |
| Verzenio | 11 | $160,358 | $14,578 |
| Eliquis | 18 | $13,012 | $723 |
| Raloxifene | 54 | $10,621 | $197 |
| Lantus Solostar | 15 | $3,921 | $261 |
| Letrozole | 101 | $3,314 | $33 |
| Erlotinib | 12 | $3,040 | $253 |
| Exemestane | 13 | $2,896 | $223 |
| Levothyroxine | 52 | $1,390 | $27 |
| Atorvastatin | 90 | $1,155 | $13 |
| Rosuvastatin | 19 | $1,093 | $58 |
| Losartan | 86 | $1,081 | $13 |
| Anastrozole | 26 | $1,058 | $41 |
| Hydroxyurea | 20 | $870 | $44 |
| Alendronate | 80 | $792 | $10 |
| Simvastatin | 79 | $598 | $8 |
| Tamsulosin | 25 | $560 | $22 |
| Ondansetron | 12 | $495 | $41 |
| Amlodipine Besylate | 63 | $473 | $8 |
| Pioglitazone | 19 | $422 | $22 |
| Loperamide | 14 | $411 | $29 |
| Potassium Chloride | 14 | $381 | $27 |
| Omeprazole | 34 | $365 | $11 |
| Famotidine | 14 | $338 | $24 |
| Metformin | 36 | $326 | $9 |
| Clopidogrel | 20 | $269 | $13 |
| Allopurinol | 17 | $256 | $15 |
| Enulose | 14 | $208 | $15 |
| Gabapentin | 18 | $177 | $10 |
| Dexamethasone | 11 | $166 | $15 |
| Metoprolol | 12 | $165 | $14 |
| Lisinopril | 20 | $161 | $8 |
| Metoprolol | 15 | $135 | $9 |
| Triamcinolone Acetonide | 14 | $74 | $5 |
| Hydrochlorothiazide | 11 | $57 | $5 |
2020: 44 drugs
| Verzenio | 13 | $173,326 | $13,333 |
| Tykerb | 12 | $73,149 | $6,096 |
| Erlotinib | 15 | $46,728 | $3,115 |
| Raloxifene | 95 | $20,415 | $215 |
| Eliquis | 12 | $5,622 | $469 |
| Exemestane | 16 | $3,448 | $215 |
| Letrozole | 113 | $2,626 | $23 |
| Levothyroxine | 77 | $1,767 | $23 |
| Atorvastatin | 100 | $1,496 | $15 |
| Rosuvastatin | 26 | $1,492 | $57 |
| Ondansetron | 30 | $1,127 | $38 |
| Megestrol Acetate | 23 | $1,039 | $45 |
| Losartan | 100 | $1,032 | $10 |
| Hydroxyurea | 35 | $939 | $27 |
| Potassium Chloride | 22 | $881 | $40 |
| Alendronate | 95 | $808 | $9 |
| Ventolin Hfa | 14 | $801 | $57 |
| Anastrozole | 30 | $786 | $26 |
| Tamoxifen Citrate | 16 | $771 | $48 |
| Simvastatin | 91 | $684 | $8 |
| Metformin | 58 | $574 | $10 |
| Bicalutamide | 23 | $570 | $25 |
| Omeprazole | 52 | $560 | $11 |
| Pioglitazone | 30 | $506 | $17 |
| Amlodipine Besylate | 88 | $467 | $5 |
| Allopurinol | 33 | $406 | $12 |
| Loperamide | 21 | $384 | $18 |
| Enulose | 24 | $371 | $15 |
| Tamsulosin | 18 | $370 | $21 |
| Metoprolol | 17 | $310 | $18 |
| Famotidine | 21 | $305 | $15 |
| Piroxicam | 11 | $283 | $26 |
| Hydrocortisone | 11 | $253 | $23 |
| Dexamethasone | 24 | $247 | $10 |
| Lisinopril | 33 | $206 | $6 |
| Clopidogrel | 18 | $201 | $11 |
| Metformin Hcl Er | 15 | $194 | $13 |
| Pravastatin | 11 | $175 | $16 |
| Zolpidem | 20 | $149 | $7 |
| Hydrochlorothiazide | 16 | $125 | $8 |
| Prednisone | 11 | $103 | $9 |
| Triamcinolone Acetonide | 15 | $103 | $7 |
| Metoprolol | 13 | $84 | $6 |
| Folic Acid | 11 | $76 | $7 |
2019: 51 drugs
| Pomalyst | 18 | $258,822 | $14,379 |
| Promacta | 11 | $191,030 | $17,366 |
| Procrit | 12 | $50,889 | $4,241 |
| Erlotinib | 11 | $48,808 | $4,437 |
| Xgeva | 12 | $29,596 | $2,466 |
| Raloxifene | 96 | $21,207 | $221 |
| Prolia | 12 | $14,941 | $1,245 |
| Exemestane | 17 | $5,212 | $307 |
| Letrozole | 88 | $2,189 | $25 |
| Levothyroxine | 103 | $2,036 | $20 |
| Atorvastatin | 98 | $1,651 | $17 |
| Ventolin Hfa | 20 | $1,592 | $80 |
| Megestrol Acetate | 38 | $1,432 | $38 |
| Tamoxifen Citrate | 30 | $1,167 | $39 |
| Rosuvastatin | 24 | $1,107 | $46 |
| Potassium Chloride | 31 | $1,079 | $35 |
| Losartan | 101 | $939 | $9 |
| Omeprazole | 43 | $913 | $21 |
| Alendronate | 97 | $825 | $9 |
| Simvastatin | 113 | $764 | $7 |
| Tamsulosin | 20 | $734 | $37 |
| Anastrozole | 35 | $724 | $21 |
| Allopurinol | 52 | $708 | $14 |
| Pioglitazone | 35 | $707 | $20 |
| Hydroxyurea | 16 | $575 | $36 |
| Ondansetron | 16 | $551 | $34 |
| Warfarin | 15 | $495 | $33 |
| Amlodipine Besylate | 84 | $474 | $6 |
| Metformin | 50 | $446 | $9 |
| Famotidine | 24 | $407 | $17 |
| Enalapril Maleate | 17 | $366 | $22 |
| Metoprolol | 13 | $352 | $27 |
| Enulose | 12 | $350 | $29 |
| Loperamide | 11 | $338 | $31 |
| Isosorbide Dinitrate | 11 | $330 | $30 |
| Bicalutamide | 13 | $327 | $25 |
| Prednisone | 40 | $273 | $7 |
| Metformin Hcl Er | 18 | $273 | $15 |
| Triamcinolone Acetonide | 45 | $268 | $6 |
| Clopidogrel | 34 | $258 | $8 |
| Oxycodone-Acetaminophen | 12 | $243 | $20 |
| Lisinopril | 38 | $223 | $6 |
| Dexamethasone | 11 | $171 | $16 |
| Zolpidem | 29 | $150 | $5 |
| Isosorbide Mononitrate Er | 14 | $99 | $7 |
| Hydrochlorothiazide | 15 | $90 | $6 |
| Azithromycin | 12 | $84 | $7 |
| Metoprolol | 13 | $79 | $6 |
| Cephalexin | 12 | $74 | $6 |
| Amoxicillin | 17 | $66 | $4 |
| Furosemide | 13 | $63 | $5 |
2018: 50 drugs
| Pomalyst | 15 | $251,554 | $16,770 |
| Zytiga | 23 | $230,930 | $10,040 |
| Promacta | 12 | $153,471 | $12,789 |
| Tarceva | 12 | $61,924 | $5,160 |
| Xgeva | 19 | $43,766 | $2,303 |
| Prolia | 17 | $20,491 | $1,205 |
| Exemestane | 27 | $11,292 | $418 |
| Raloxifene | 75 | $10,581 | $141 |
| Atrovent Hfa | 11 | $5,326 | $484 |
| Omega-3 Acid Ethyl Esters | 14 | $2,496 | $178 |
| Levothyroxine | 104 | $2,215 | $21 |
| Atorvastatin | 97 | $1,585 | $16 |
| Letrozole | 61 | $1,481 | $24 |
| Simvastatin | 130 | $1,192 | $9 |
| Hydroxyurea | 23 | $1,150 | $50 |
| Ventolin Hfa | 20 | $1,147 | $57 |
| Lactulose | 29 | $1,086 | $37 |
| Losartan | 93 | $1,080 | $12 |
| Pioglitazone | 40 | $1,020 | $26 |
| Potassium Chloride | 28 | $1,003 | $36 |
| Rosuvastatin | 19 | $943 | $50 |
| Tamoxifen Citrate | 20 | $831 | $42 |
| Amlodipine Besylate | 71 | $793 | $11 |
| Alendronate | 98 | $724 | $7 |
| Anastrozole | 29 | $705 | $24 |
| Metoprolol | 20 | $614 | $31 |
| Metformin | 66 | $612 | $9 |
| Metformin Hcl Er | 20 | $600 | $30 |
| Allopurinol | 29 | $589 | $20 |
| Clopidogrel | 42 | $542 | $13 |
| Tamsulosin | 37 | $525 | $14 |
| Omeprazole | 29 | $475 | $16 |
| Bicalutamide | 13 | $447 | $34 |
| Betamethasone Valerate | 13 | $413 | $32 |
| Warfarin | 11 | $401 | $36 |
| Dexamethasone | 21 | $399 | $19 |
| Prednisone | 46 | $372 | $8 |
| Isosorbide Dinitrate | 12 | $360 | $30 |
| Famotidine | 42 | $327 | $8 |
| Lisinopril | 34 | $317 | $9 |
| Sertraline | 11 | $245 | $22 |
| Valsartan | 11 | $210 | $19 |
| Zolpidem | 33 | $203 | $6 |
| Isosorbide Mononitrate Er | 16 | $197 | $12 |
| Triamcinolone Acetonide | 23 | $189 | $8 |
| Furosemide | 24 | $158 | $7 |
| Atenolol | 29 | $157 | $5 |
| Amoxicillin | 22 | $140 | $6 |
| Metoprolol | 13 | $101 | $8 |
| Fosinopril | 12 | $60 | $5 |
2017: 46 drugs
| Revlimid | 13 | $157,301 | $12,100 |
| Zytiga | 14 | $128,682 | $9,192 |
| Tarceva | 21 | $119,120 | $5,672 |
| Gilotrif | 12 | $97,876 | $8,156 |
| Procrit | 15 | $59,289 | $3,953 |
| Prolia | 11 | $12,331 | $1,121 |
| Exemestane | 19 | $9,524 | $501 |
| Raloxifene | 52 | $9,113 | $175 |
| Advair Diskus | 16 | $7,236 | $452 |
| Atrovent Hfa | 11 | $5,628 | $512 |
| Omega-3 Acid Ethyl Esters | 15 | $3,775 | $252 |
| Levothyroxine | 84 | $1,762 | $21 |
| Atorvastatin | 76 | $1,342 | $18 |
| Rosuvastatin | 22 | $1,335 | $61 |
| Letrozole | 61 | $1,263 | $21 |
| Simvastatin | 110 | $1,028 | $9 |
| Lactulose | 33 | $1,024 | $31 |
| Tamoxifen Citrate | 22 | $960 | $44 |
| Losartan | 76 | $849 | $11 |
| Pioglitazone | 22 | $699 | $32 |
| Alendronate | 53 | $547 | $10 |
| Amlodipine Besylate | 57 | $521 | $9 |
| Megestrol Acetate | 12 | $502 | $42 |
| Metformin | 43 | $490 | $11 |
| Anastrozole | 25 | $485 | $19 |
| Tamsulosin | 31 | $460 | $15 |
| Metoprolol | 12 | $445 | $37 |
| Omeprazole | 36 | $385 | $11 |
| Clopidogrel | 39 | $380 | $10 |
| Potassium Chloride | 11 | $380 | $35 |
| Isosorbide Dinitrate | 12 | $360 | $30 |
| Betamethasone Valerate | 13 | $340 | $26 |
| Warfarin | 12 | $247 | $21 |
| Famotidine | 29 | $190 | $7 |
| Furosemide | 15 | $179 | $12 |
| Prednisone | 20 | $167 | $8 |
| Isosorbide Mononitrate Er | 14 | $164 | $12 |
| Amoxicillin | 20 | $118 | $6 |
| Lisinopril | 23 | $117 | $5 |
| Dexamethasone | 23 | $113 | $5 |
| Triamcinolone Acetonide | 14 | $108 | $8 |
| Gabapentin | 13 | $105 | $8 |
| Atenolol | 19 | $92 | $5 |
| Metoprolol | 12 | $85 | $7 |
| Fosinopril | 12 | $82 | $7 |
| Glipizide | 12 | $58 | $5 |
2016: 35 drugs
| Revlimid | 19 | $208,564 | $10,977 |
| Tarceva | 20 | $103,117 | $5,156 |
| Zytiga | 11 | $96,065 | $8,733 |
| Procrit | 26 | $94,931 | $3,651 |
| Prolia | 13 | $13,190 | $1,015 |
| Raloxifene | 41 | $9,318 | $227 |
| Exemestane | 11 | $6,264 | $569 |
| Crestor | 18 | $5,369 | $298 |
| Tradjenta | 11 | $4,008 | $364 |
| Omega-3 Acid Ethyl Esters | 20 | $2,616 | $131 |
| Letrozole | 69 | $1,496 | $22 |
| Levothyroxine | 48 | $885 | $18 |
| Tamoxifen Citrate | 23 | $845 | $37 |
| Metoprolol | 22 | $572 | $26 |
| Atorvastatin | 34 | $518 | $15 |
| Simvastatin | 44 | $493 | $11 |
| Losartan | 44 | $489 | $11 |
| Tamsulosin | 22 | $467 | $21 |
| Alendronate | 45 | $444 | $10 |
| Anastrozole | 25 | $407 | $16 |
| Clopidogrel | 19 | $391 | $21 |
| Lactulose | 25 | $333 | $13 |
| Potassium Chloride | 15 | $287 | $19 |
| Pravastatin | 18 | $266 | $15 |
| Amlodipine Besylate | 26 | $221 | $9 |
| Pioglitazone | 12 | $201 | $17 |
| Metformin | 17 | $191 | $11 |
| Omeprazole | 18 | $189 | $11 |
| Dexamethasone | 23 | $165 | $7 |
| Prednisone | 16 | $99 | $6 |
| Famotidine | 12 | $74 | $6 |
| Metoprolol | 12 | $55 | $5 |
| Zolpidem | 14 | $43 | $3 |
| Atenolol | 16 | $40 | $3 |
| Furosemide | 13 | $30 | $2 |
2015: 33 drugs
| Revlimid | 23 | $236,407 | $10,279 |
| Tarceva | 27 | $158,929 | $5,886 |
| Procrit | 15 | $51,563 | $3,438 |
| Prolia | 13 | $12,223 | $940 |
| Crestor | 33 | $8,230 | $249 |
| Raloxifene | 35 | $7,015 | $200 |
| Spiriva | 19 | $5,963 | $314 |
| Tradjenta | 12 | $3,985 | $332 |
| Omega-3 Acid Ethyl Esters | 19 | $3,086 | $162 |
| Letrozole | 51 | $1,292 | $25 |
| Atorvastatin | 29 | $671 | $23 |
| Betamethasone Valerate | 20 | $594 | $30 |
| Glimepiride | 15 | $570 | $38 |
| Levothyroxine | 23 | $544 | $24 |
| Metoprolol | 21 | $413 | $20 |
| Alendronate | 38 | $403 | $11 |
| Anastrozole | 21 | $403 | $19 |
| Potassium Chloride | 17 | $391 | $23 |
| Pravastatin | 17 | $310 | $18 |
| Pioglitazone | 20 | $270 | $13 |
| Omeprazole | 26 | $257 | $10 |
| Fluticasone Propionate | 27 | $212 | $8 |
| Pantoprazole | 20 | $201 | $10 |
| Losartan | 24 | $173 | $7 |
| Simvastatin | 29 | $170 | $6 |
| Lactulose | 19 | $163 | $9 |
| Amlodipine Besylate | 27 | $144 | $5 |
| Tramadol | 15 | $120 | $8 |
| Hydrochlorothiazide | 12 | $62 | $5 |
| Trazodone | 15 | $51 | $3 |
| Furosemide | 17 | $47 | $3 |
| Lisinopril | 11 | $38 | $3 |
| Zolpidem | 16 | $37 | $2 |
2014: 24 drugs
| Tarceva | 56 | $311,174 | $5,557 |
| Revlimid | 16 | $142,387 | $8,899 |
| Procrit | 24 | $62,897 | $2,621 |
| Prolia | 13 | $11,505 | $885 |
| Raloxifene | 15 | $3,538 | $236 |
| Metoprolol | 19 | $1,052 | $55 |
| Letrozole | 27 | $1,029 | $38 |
| Betamethasone Valerate | 16 | $766 | $48 |
| Atorvastatin | 22 | $579 | $26 |
| Megestrol Acetate | 12 | $542 | $45 |
| Proair Hfa | 11 | $540 | $49 |
| Potassium Chloride | 16 | $433 | $27 |
| Omeprazole | 45 | $424 | $9 |
| Alendronate | 30 | $401 | $13 |
| Levothyroxine | 23 | $370 | $16 |
| Pioglitazone | 15 | $346 | $23 |
| Simvastatin | 21 | $165 | $8 |
| Amlodipine Besylate | 21 | $148 | $7 |
| Prednisone | 14 | $118 | $8 |
| Famotidine | 17 | $110 | $6 |
| Gabapentin | 11 | $107 | $10 |
| Losartan | 14 | $99 | $7 |
| Furosemide | 16 | $72 | $4 |
| Metoprolol | 12 | $56 | $5 |
2013: 19 drugs
| Tarceva | 60 | $297,493 | $4,958 |
| Revlimid | 16 | $134,689 | $8,418 |
| Procrit | 27 | $63,385 | $2,348 |
| Prolia | 22 | $18,902 | $859 |
| Evista | 31 | $8,468 | $273 |
| Piroxicam | 13 | $810 | $62 |
| Letrozole | 22 | $691 | $31 |
| Megestrol Acetate | 16 | $639 | $40 |
| Betamethasone Valerate | 15 | $450 | $30 |
| Alendronate | 29 | $363 | $13 |
| Atorvastatin | 14 | $349 | $25 |
| Tamoxifen Citrate | 13 | $268 | $21 |
| Omeprazole | 23 | $225 | $10 |
| Simvastatin | 12 | $179 | $15 |
| Famotidine | 20 | $156 | $8 |
| Pravastatin | 12 | $148 | $12 |
| Amlodipine Besylate | 11 | $140 | $13 |
| Prednisone | 14 | $75 | $5 |
| Dexamethasone | 17 | $74 | $4 |
Money from drug and device companies
$737 in 2025
| 2025 | 17 | 29 | None | $737 |
| 2024 | 8 | 11 | None | $332 |
| 2023 | 8 | 21 | None | $545 |
| 2022 | 18 | 40 | None | $1,004 |
| 2021 | 21 | 43 | None | $1,014 |
| 2020 | 17 | 33 | None | $647 |
| 2019 | 29 | 123 | None | $2,374 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Pluvicto | $143 | 5 payments
|
| GlaxoSmithKline | Ojjaara | $69 | 3 payments
|
| Progenics Pharmaceuticals | Pylarify | $66 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $65 | 3 payments
|
| Lilly USA | Jaypirca | $61 | 2 payments
|
| Eisai | Lenvima | $49 | 2 payments
|
See all 29 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-10 | Pluvicto | $27 |
| Kite Pharma | Meals · 2025-12-03 | Yescarta | $24 |
| Progenics Pharmaceuticals | Meals · 2025-11-19 | Pylarify | $23 |
| BeOne Medicines USA | Meals · 2025-11-11 | Brukinsa | $30 |
| Novartis Pharmaceuticals | Meals · 2025-10-22 | Kisqali | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Imfinzi | $20 |
| GlaxoSmithKline | Meals · 2025-10-01 | Ojjaara | $22 |
| GlaxoSmithKline | Meals · 2025-09-10 | Ojjaara | $20 |
| Progenics Pharmaceuticals | Meals · 2025-09-03 | Pylarify | $16 |
| Merck Sharp & Dohme | Meals · 2025-08-28 | Keytruda | $27 |
| Novartis Pharmaceuticals | Meals · 2025-08-27 | Pluvicto | $17 |
| Eisai | Meals · 2025-08-13 | Lenvima | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-30 | Opdivo | $21 |
| Daiichi Sankyo | Meals · 2025-07-23 | Enhertu | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-09 | Imfinzi | $24 |
| Novartis Pharmaceuticals | Meals · 2025-07-02 | Kisqali | $36 |
| Gilead Sciences | Meals · 2025-06-25 | Trodelvy | $20 |
| Eisai | Meals · 2025-06-16 | Lenvima | $28 |
| Array Biopharma | Meals · 2025-06-05 | Xalkori | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-28 | Calquence | $21 |
| GlaxoSmithKline | Meals · 2025-05-22 | Ojjaara | $27 |
| Abbvie | Meals · 2025-05-21 | Elahere | $31 |
| Lilly USA | Meals · 2025-05-14 | Jaypirca | $31 |
| Progenics Pharmaceuticals | Meals · 2025-05-07 | Pylarify | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-24 | Advate | $23 |
| Lilly USA | Meals · 2025-03-26 | Verzenio | $30 |
| Astellas Pharma US | Meals · 2025-03-12 | Xtandi | $25 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Pluvicto | $30 |
| Blueprint Medicines | Meals · 2025-02-27 | Ayvakit | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $332
| Janssen Biotech | Darzalex | $116 | 2 payments
|
| Novartis Pharmaceuticals | Scemblix | $67 | 2 payments
|
| Abbvie | Imbruvica | $41 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $30 | 1 payment
|
| GlaxoSmithKline | Ojjaara | $24 | 1 payment
|
| Eisai | Lenvima | $22 | 1 payment
|
| Amgen | Evenity | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $14 | 1 payment
|
2023: $545
| E.R. Squibb & Sons L.L.C. | Opdivo | $152 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $132 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $125 | 1 payment
|
| Astellas Pharma US | Padcev | $32 | 1 payment
|
| EMD Serono | Tepmetko | $27 | 1 payment
|
| Gilead Sciences | None | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $26 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $24 | 1 payment
|
2022: $1,004
| Janssen Biotech | Imbruvica | $198 | 5 payments
|
| Lilly USA | Verzenio | $154 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $106 | 4 payments
|
| Novartis Pharmaceuticals | Kisqali | $86 | 4 payments
|
| Clovis Oncology | Rubraca | $54 | 3 payments
|
| GlaxoSmithKline | Blenrep | $49 | 2 payments
|
| Seagen | Adcetris | $49 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $43 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $41 | 2 payments
|
| Puma Biotechnology | Nerlynx | $28 | 1 payment
|
| Eisai | Lenvima | $25 | 1 payment
|
| Sobi | Doptelet | $25 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $22 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $22 | 1 payment
|
| Celgene | Pomalyst | $21 | 1 payment
|
| Astellas Pharma US | Padcev | $17 | 1 payment
|
| Gilead Sciences | Trodelvy | $16 | 1 payment
|
2021: $1,014
| Astellas Pharma US | Padcev | $213 | 7 payments
|
| Novartis Pharmaceuticals | Lutathera | $101 | 5 payments
|
| Lilly USA | Verzenio | $87 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | None | $64 | 3 payments
|
| Janssen Biotech | Erleada | $56 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $46 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $44 | 2 payments
|
| Seagen | Tukysa | $44 | 2 payments
|
| Array Biopharma | Braftovi | $43 | 2 payments
|
| Eisai | Lenvima | $41 | 2 payments
|
| Incyte | Monjuvi | $40 | 2 payments
|
| Aveo Pharmaceuticals | Fotivda | $32 | 1 payment
|
| Amgen | Nplate | $30 | 1 payment
|
| GlaxoSmithKline | Blenrep | $27 | 1 payment
|
| Pfizer | Inlyta | $26 | 1 payment
|
| Puma Biotechnology | Nerlynx | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $23 | 1 payment
|
| Dova Pharmaceuticals | Doptelet | $23 | 1 payment
|
| Clovis Oncology | Rubraca | $19 | 1 payment
|
| Celgene | Inrebic | $16 | 1 payment
|
| Foundation Medicine | Foundationone | $15 | 1 payment
|
2020: $647
| Pfizer | Ibrance | $124 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | None | $70 | 4 payments
|
| GlaxoSmithKline | Blenrep | $68 | 3 payments
|
| Janssen Biotech | Darzalex | $58 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $49 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $38 | 2 payments
|
| Celgene | Pomalyst | $34 | 2 payments
|
| Astellas Pharma US | Padcev | $21 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $19 | 1 payment
|
| Dova Pharmaceuticals | Doptelet | $19 | 1 payment
|
| Seagen | Padcev | $19 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $19 | 1 payment
|
| Lilly USA | Cyramza | $18 | 1 payment
|
| Genentech USA | Alecensa | $17 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $15 | 1 payment
|
| Array Biopharma | Braftovi | $15 | 1 payment
|
2019: $2,374
| Pfizer | Ibrance | $303 | 23 payments
|
| Janssen Biotech | Erleada | $245 | 7 payments
|
| Novartis Pharmaceuticals | Promacta | $236 | 11 payments
|
| Takeda Pharmaceuticals U.S.A. | Velcade | $166 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Empliciti | $147 | 16 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $145 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $130 | 6 payments
|
| Genentech USA | Tecentriq | $130 | 6 payments
|
| Lilly USA | Cyramza | $121 | 7 payments
|
| Merck Sharp & Dohme | Keytruda | $107 | 6 payments
|
| Foundation Medicine | Foundationone | $94 | 3 payments
|
| Celgene | Revlimid | $70 | 3 payments
|
| Incyte | Jakafi | $67 | 3 payments
|
| EMD Serono | Bavencio | $52 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $48 | 1 payment
|
| Astellas Pharma US | Xtandi | $42 | 2 payments
|
| Amgen | Kyprolis | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $28 | 1 payment
|
| Taiho Oncology | Lonsurf | $27 | 1 payment
|
| Clovis Oncology | Rubraca | $26 | 2 payments
|
| Genzyme | Elitek | $24 | 1 payment
|
| Seattle Genetics | Adcetris | $22 | 1 payment
|
| Array BioPharma | Braftovi | $22 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $18 | 1 payment
|
| Puma Biotechnology | Nerlynx | $17 | 1 payment
|
| Eisai | Lenvima | $16 | 1 payment
|
| Vyera Pharmaceuticals | Daraprim 30 Tablet in 1 Bottle | $16 | 1 payment
|
| Dova Pharmaceuticals | Doptelet | $14 | 1 payment
|
| Janssen Pharmaceuticals | Darzalex | $10 | 1 payment
|
Professional record
- NPI
- 1326098179
- Licence
- CA A36657California A36657: Current · expires 2028-06-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CO 00A366570
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
- Mailing address
- 200 Jose Figueres Ave, Suite 430, San Jose, CA, 95116
- NPI first listed
- 2006-05-11
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.